Drug
Hicm 188 Cells
Hicm 188 Cells: highest development phase Phase 1/2, developed by HELP Therapeutics, Inc.. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- HELP Therapeutics, Inc.
Trials
| Drug | Phase | Indication |
|---|---|---|
| HiCM-188 Cells NCT07646210 | Phase 1/2 | Advanced Heart Failure |
Latest
No recent events.
Follow Hicm 188 Cells on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.